Platelets Recognize Brain-Specific Glycolipid Structures, Respond to Neurovascular Damage and Promote Neuroinflammation

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Sotnikov, Ilya ^a,b   Veremeyko, Tatyana ^a   Starossom, Sarah C ^a   Barteneva, Natalia ^a   Weiner, Howard L ^a   Ponomarev, Eugene D ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM1; GANGLIOSIDE GQ 1B; GANGLIOSIDE GT 1B; GLYCOLIPID; GLYCOSPHINGOLIPID; PADGEM PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL INTERACTION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; GRANULOCYTOSIS; LYMPHOCYTIC INFILTRATION; MACROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NERVOUS SYSTEM INJURY; NEUROPATHOLOGY; NONHUMAN; PARENCHYMA; PHENOTYPE; RAT; STRUCTURE ANALYSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ANAPHYLAXIS; ANIMALS; ASTROCYTES; BIOLOGICAL TRANSPORT; BLOOD PLATELETS; BLOOD-BRAIN BARRIER; BRAIN; CELL DEGRANULATION; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR DISORDERS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GANGLIOSIDES; GLYCOLIPIDS; INFLAMMATION; MEMBRANE MICRODOMAINS; MICE; NEURONS; PROTEIN BINDING; RECEPTORS, CELL SURFACE;

MUS;

EID: 84875445669     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058979     Document Type: Article

References (86)

1. Junt T, Schulze H, Chen Z, Massberg S, Goerge T, et al. (2007) Dynamic visualization of thrombopoiesis within bone marrow. Science 317: 1767-1770.
2. Zucker-Franklin D, Philipp CS, (2000) Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept. Am J Pathol 157: 69-74.
3. Semple JW, Freedman J, (2010) Platelets and innate immunity. Cell Mol Life Sci 67: 499-511.
4. McNicol A, Israels SJ, (2008) Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets 8: 99-117.
5. Weyrich AS, Lindemann S, Zimmerman GA, (2003) The evolving role of platelets in inflammation. J Thromb Haemost 1: 1897-1905.
6. Erpenbeck L, Schon MP, (2010) Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 115: 3427-3436.
7. Jabbar AA, Kazarian T, Hakobyan N, Valentino LA, (2006) Gangliosides promote platelet adhesion and facilitate neuroblastoma cell adhesion under dynamic conditions simulating blood flow. Pediatr Blood Cancer 46: 292-299.
8. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, et al. (2010) Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327: 580-583.
9. Verschoor A, Neuenhahn M, Navarini AA, Graef P, Plaumann A, et al. (2011) A platelet-mediated system for shuttling blood-borne bacteria to CD8alpha+ dendritic cells depends on glycoprotein GPIb and complement C3. Nat Immunol 12: 1194-1201.
10. Jirouskova M, Shet AS, Johnson GJ, (2007) A guide to murine platelet structure, function, assays, and genetic alterations. J Thromb Haemost 5: 661-669.
11. Jain S, Harris J, Ware J, (2010) Platelets: linking hemostasis and cancer. Arterioscler Thromb Vasc Biol 30: 2362-2367.
12. Horstman LL, Jy W, Ahn YS, Zivadinov R, Maghzi AH, et al. (2010) Role of platelets in neuroinflammation: a wide-angle perspective. J Neuroinflammation 7: 10.
13. Sevush S, Jy W, Horstman LL, Mao WW, Kolodny L, et al. (1998) Platelet activation in Alzheimer disease. Arch Neurol 55: 530-536.
14. Ciabattoni G, Porreca E, Di Febbo C, Di Iorio A, Paganelli R, et al. (2007) Determinants of platelet activation in Alzheimer's disease. Neurobiol Aging 28: 336-342.
15. Sheremata WA, Jy W, Horstman LL, Ahn YS, Alexander JS, et al. (2008) Evidence of platelet activation in multiple sclerosis. J Neuroinflammation 5: 27.
16. Wright HP, Thompson RH, Zilkha KJ, (1965) Platelet adhesiveness in multiple sclerosis. Lancet 2: 1109-1110.
17. Cananzi AR, Ferro-Milone F, Grigoletto F, Toldo M, Meneghini F, et al. (1987) Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis. Acta Neurol Scand 76: 79-85.
18. Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, et al. (2009) Platelet functions beyond hemostasis. J Thromb Haemost 7: 1759-1766.
19. Langer HF, Choi EY, Zhou H, Schleicher R, Chung KJ, et al. (2012) Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res 110: 1202-1210.
20. Banerjee S, Bhat MA, (2007) Neuron-glial interactions in blood-brain barrier formation. Annu Rev Neurosci 30: 235-258.
21. Abbott NJ, (2005) Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 25: 5-23.
22. McCarty JH, (2009) Cell adhesion and signaling networks in brain neurovascular units. Curr Opin Hematol 16: 209-214.
23. Minagar A, Alexander JS, (2003) Blood-brain barrier disruption in multiple sclerosis. Mult Scler 9: 540-549.
24. Munoz JJ, Peacock MG, Hadlow WJ, (1987) Anaphylaxis or so-called encephalopathy in mice sensitized to an antigen with the aid of pertussigen (pertussis toxin). Infect Immun 55: 1004-1008.
25. Zibitsker DE (1961) [State of autosensibilisation to brain allergen]. In Russian. Journal of Scientific Articles of Byelorussian Institute of Epidemiology, Microbiology & Hygiene, Minsk, USSR: 143-150.
26. Gresele P, Momi S, Berrettini M, Nenci GG, Schwarz HP, et al. (1998) Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. J Clin Invest 101: 667-676.
27. Prinetti A, Loberto N, Chigorno V, Sonnino S, (2009) Glycosphingolipid behaviour in complex membranes. Biochim Biophys Acta 1788: 184-193.
28. Ledeen RW, (1978) Ganglioside structures and distribution: are they localized at the nerve ending? J Supramol Struct 8: 1-17.
29. Sato C, Matsuda T, Kitajima K, (2002) Neuronal differentiation-dependent expression of the disialic acid epitope on CD166 and its involvement in neurite formation in Neuro2A cells. J Biol Chem 277: 45299-45305.
30. Lian T, Ho RJ, (1997) Cholera toxin B-mediated targeting of lipid vesicles containing ganglioside GM1 to mucosal epithelial cells. Pharm Res 14: 1309-1315.
31. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, et al. (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28: 41-51.
32. Chronos NA, Goodall AH, Wilson DJ, Sigwart U, Buller NP, (1993) Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation 88: 2035-2044.
33. Ohba M, Shibazaki M, Sasano T, Inoue M, Takada H, et al. (2004) Platelet responses and anaphylaxis-like shock induced in mice by intravenous injection of whole cells of oral streptococci. Oral Microbiol Immunol 19: 26-30.
34. Mazurov AV, Prokazova NV, Mikhailenko IA, Mukjin DN, Repin VS, et al. (1988) Stimulation of platelet adhesion and activation by ganglioside GD3 adsorbed to plastic. Biochim Biophys Acta 968: 167-171.
35. Lopez PH, Schnaar RL, (2009) Gangliosides in cell recognition and membrane protein regulation. Curr Opin Struct Biol 19: 549-557.
36. Lehmann F, Tiralongo E, Tiralongo J, (2006) Sialic acid-specific lectins: occurrence, specificity and function. Cell Mol Life Sci 63: 1331-1354.
37. Han S, Collins BE, Bengtson P, Paulson JC, (2005) Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. Nat Chem Biol 1: 93-97.
38. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM, (1998) Platelets exit venules by a transcellular pathway at sites of F-met peptide-induced acute inflammation in guinea pigs. Int Arch Allergy Immunol 116: 188-195.
39. Lu C, Pelech S, Zhang H, Bond J, Spach K, et al. (2008) Pertussis toxin induces angiogenesis in brain microvascular endothelial cells. J Neurosci Res 86: 2624-2640.
40. Tonra JR, Reiseter BS, Kolbeck R, Nagashima K, Robertson R, et al. (2001) Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis. J Comp Neurol 430: 131-144.
41. Bennett J, Basivireddy J, Kollar A, Biron KE, Reickmann P, et al. (2010) Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J Neuroimmunol 229: 180-191.
42. Seidel G, Bocker K, Schulte J, Wewer C, Greune L, et al. (2011) Pertussis toxin permeabilization enhances the traversal of Escherichia coli K1, macrophages, and monocytes in a cerebral endothelial barrier model in vitro. Int J Med Microbiol 301: 204-212.
43. Wilhelm I, Fazakas C, Krizbai IA, (2011) In vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars) 71: 113-128.
44. Yoshida A, Ohba M, Wu X, Sasano T, Nakamura M, et al. (2002) Accumulation of platelets in the lung and liver and their degranulation following antigen-challenge in sensitized mice. Br J Pharmacol 137: 146-152.
45. Kowalska MA, Rauova L, Poncz M, (2010) Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. Thromb Res 125: 292-296.
46. Bakry N, Kamata Y, Simpson LL, (1991) Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin. J Pharmacol Exp Ther 258: 830-836.
47. Kim SU, Moretto G, Lee V, Yu RK, (1986) Neuroimmunology of gangliosides in human neurons and glial cells in culture. J Neurosci Res 15: 303-321.
48. Proia RL, (2004) Gangliosides help stabilize the brain. Nat Genet 36: 1147-1148.
49. Racke MK, Hu W, Lovett-Racke AE, (2005) PTX cruiser: driving autoimmunity via TLR4. Trends Immunol 26: 289-291.
50. Gagneux P, Cheriyan M, Hurtado-Ziola N, van der Linden EC, Anderson D, et al. (2003) Human-specific regulation of alpha 2-6-linked sialic acids. J Biol Chem 278: 48245-48250.
51. Cserr HF, Bundgaard M, (1984) Blood-brain interfaces in vertebrates: a comparative approach. Am J Physiol 246: R277-288.
52. Varki NM, Varki A, (2007) Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest 87: 851-857.
53. Grewal PK, Uchiyama S, Ditto D, Varki N, Le DT, et al. (2008) The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 14: 648-655.
54. Stenberg PE, Levin J, Baker G, Mok Y, Corash L, (1991) Neuraminidase-induced thrombocytopenia in mice: effects on thrombopoiesis. J Cell Physiol 147: 7-16.
55. Vomel T, Hager K, Platt D, (1985) Aging in vivo and neuraminidase treatment of rat erythrocytes and their sequestration by the isolated perfused rat liver. Arch Gerontol Geriatr 4: 125-132.
56. Mandic R, Opper C, Krappe J, Wesemann W, (2002) Platelet sialic acid as a potential pathogenic factor in coronary heart disease. Thromb Res 106: 137-141.
57. Kijima-Suda I, Miyazawa T, Itoh M, Toyoshima S, Osawa T, (1988) Possible mechanism of inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid: nucleoside conjugate. Cancer Res 48: 3728-3732.
58. Wen FQ, Jabbar AA, Patel DA, Kazarian T, Valentino LA, (1999) Atherosclerotic aortic gangliosides enhance integrin-mediated platelet adhesion to collagen. Arterioscler Thromb Vasc Biol 19: 519-524.
59. Freire E, Gomes FC, Jotha-Mattos T, Neto VM, Silva Filho FC, et al. (2004) Sialic acid residues on astrocytes regulate neuritogenesis by controlling the assembly of laminin matrices. J Cell Sci 117: 4067-4076.
60. Takamiya K, Yamamoto A, Furukawa K, Zhao J, Fukumoto S, et al. (1998) Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosterone. Proc Natl Acad Sci U S A 95: 12147-12152.
61. Saito M, Sugiyama K, (2000) A distinct ganglioside composition of rat pancreatic islets. Arch Biochem Biophys 376: 371-376.
62. Gore PJ, Singh SP, Brooks DE, (1986) Composition of gangliosides from ovine testis and spermatozoa. Biochim Biophys Acta 876: 36-47.
63. Regina Todeschini A, Hakomori SI, (2008) Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta 1780: 421-433.
64. Jung JE, Kim GS, Chen H, Maier CM, Narasimhan P, et al. (2010) Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol 41: 172-179.
65. Yanagisawa K, (2007) Role of gangliosides in Alzheimer's disease. Biochim Biophys Acta 1768: 1943-1951.
66. Vetrivel KS, Thinakaran G, (2010) Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim Biophys Acta 1801: 860-867.
67. Miklossy J, Qing H, Radenovic A, Kis A, Vileno B, et al. (2010) Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging 31: 1503-1515.
68. Chen M, Inestrosa NC, Ross GS, Fernandez HL, (1995) Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Commun 213: 96-103.
69. Stoll G, Kleinschnitz C, Nieswandt B, (2008) Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood 112: 3555-3562.
70. Gaglia MA Jr, Manoukian SV, Waksman R, (2010) Novel antiplatelet therapy. Am Heart J 160: 595-604.
71. Franks ZG, Campbell RA, Weyrich AS, Rondina MT, (2010) Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke. Ann N Y Acad Sci 1207: 11-17.
72. Armstrong RC, (1998) Isolation and characterization of immature oligodendrocyte lineage cells. Methods 16: 282-292.
73. Suzumura A, Bhat S, Eccleston PA, Lisak RP, Silberberg DH, (1984) The isolation and long-term culture of oligodendrocytes from newborn mouse brain. Brain Res 324: 379-383.
74. Brewer GJ, Torricelli JR, (2007) Isolation and culture of adult neurons and neurospheres. Nat Protoc 2: 1490-1498.
75. Kim J, Krichevsky A, Grad Y, Hayes GD, Kosik KS, et al. (2004) Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc Natl Acad Sci U S A 101: 360-365.
76. Ge S, Pachter JS, (2006) Isolation and culture of microvascular endothelial cells from murine spinal cord. J Neuroimmunol 177: 209-214.
77. Qi F, Adair A, Ferenbach D, Vass DG, Mylonas KJ, et al. (2008) Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation. Transplantation 86: 1267-1274.
78. van Rooijen N, van Kesteren-Hendrikx E, (2003) "In vivo" depletion of macrophages by liposome-mediated "suicide". Methods Enzymol 373: 3-16.
79. Persaud-Sawin DA, Lightcap S, Harry GJ, (2009) Isolation of rafts from mouse brain tissue by a detergent-free method. J Lipid Res 50: 759-767.
80. Di Biase A, Salvati S, Serlupi Crescenzi G, (1990) Lipid profile of rat myelin subfractions. Neurochem Res 15: 519-522.
81. Debruin LS, Harauz G, (2007) White matter rafting-membrane microdomains in myelin. Neurochem Res 32: 213-228.
82. Nutikka A, Lingwood C, (2004) Generation of receptor-active, globotriaosyl ceramide/cholesterol lipid 'rafts' in vitro: A new assay to define factors affecting glycosphingolipid receptor activity. Glycoconj J 20: 33-38.
83. Walkowiak B, Kralisz U, Michalec L, Majewska E, Koziolkiewicz W, et al. (2000) Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods. Thromb Res 99: 495-502.
84. Rapoport E, Mikhalyov I, Zhang J, Crocker P, Bovin N, (2003) Ganglioside binding pattern of CD33-related siglecs. Bioorg Med Chem Lett 13: 675-678.
85. Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL, (2011) MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med 17: 64-70.
86. Marie D, Brussaard CPD, Thyrhaug R, Bratbak G, Vaulot D, (1999) Enumeration of marine viruses in culture and natural samples by flow cytometry. Appl Environ Microbiol 65: 45-52.